Instil Bio, Inc. (TIL)
NASDAQ: TIL · Real-Time Price · USD
8.08
-0.05 (-0.62%)
At close: Apr 28, 2026, 4:00 PM EDT
8.18
+0.10 (1.18%)
After-hours: Apr 28, 2026, 4:10 PM EDT
Instil Bio Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Market Capitalization | 55 | 75 | 125 | 50 | 82 | 2,206 | |
| Market Cap Growth | -44.13% | -40.12% | 151.37% | -39.38% | -96.29% | - | |
| Enterprise Value | 64 | 80 | 89 | -48 | -151 | 1,691 | |
| Last Close Price | 8.08 | 11.00 | 19.09 | 7.62 | 12.60 | 342.20 | |
| PB Ratio | 0.48 | 0.66 | 0.74 | 0.22 | 0.23 | 3.97 | |
| P/TBV Ratio | 0.48 | 0.66 | 0.74 | 0.22 | 0.23 | 4.09 | |
| Debt / Equity Ratio | 0.75 | 0.75 | 0.51 | 0.38 | 0.22 | - | |
| Net Debt / Equity Ratio | 0.08 | 0.08 | -0.16 | -0.29 | -0.50 | -0.82 | |
| Net Debt / EBITDA Ratio | -0.17 | -0.17 | 0.47 | 0.76 | 0.92 | 2.98 | |
| Net Debt / FCF Ratio | -0.25 | -0.25 | 0.48 | 0.64 | 0.69 | 2.52 | |
| Quick Ratio | 15.89 | 15.89 | 14.68 | 14.34 | 8.03 | 10.98 | |
| Current Ratio | 39.53 | 39.53 | 15.76 | 15.23 | 8.22 | 11.22 | |
| Return on Equity (ROE) | -50.39% | -50.39% | -37.51% | -52.96% | -48.58% | -37.00% | |
| Return on Assets (ROA) | -14.16% | -14.16% | -12.72% | -14.01% | -23.60% | -20.89% | |
| Return on Capital Employed (ROCE) | -26.60% | -26.60% | -23.50% | -28.70% | -45.90% | -27.30% | |
| Earnings Yield | -130.24% | -95.67% | -59.51% | -314.94% | -272.97% | -7.11% | |
| FCF Yield | -66.82% | -49.09% | -44.71% | -207.21% | -323.82% | -8.16% | |
| Buyback Yield / Dilution | -2.43% | -2.43% | -0.10% | -0.44% | -22.19% | -562.55% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.